EarliTec Dx Scores $19.5 Million for Autism Diagnostics

Digital tool for autism detection EarliTec Dx announced $19.5 million in a Series A funding round led by Bernie Marcus with participation from Georgia Research Alliance (GRA).


The Atlanta-based startup uses digital biomarkers to diagnose developmental disorders. Notably, it has developed a tool that uses Dynamic Quantification of Social-Visual Engagement (DQSVE), which quantifies eye movements and viewing behavior, to diagnose autism.

Kids watch a video and the tool can access “individual focal points at a rate of 120 times per second.” According to the company, viewing behavior can help detect neurodevelopmental disorders.

Researchers from Children’s Healthcare of Atlanta, Emory School of Medicine and Yale University worked to develop the product, which has been used in multiple clinical studies.

The technology is not currently for sale in the US and does not have FDA approval.


The new cash infusion is expected to help the company with its 510(k) filing with the FDA. It also aims to fuel the commercialization and expansion efforts of its AI-based platform.

“EarliTec’s ability to measure clinically relevant responses to unscripted social situations is revolutionizing our understanding of how young children with autism learn about their social world,” said Tom Ressemann, CEO of EarliTec. “With this insight, we can help parents, caregivers and caregivers access earlier diagnoses at a time when effective intervention dramatically improves life outcomes.”


Autism is a common condition in the United States. In fact, one in 44 children has been diagnosed with an autism spectrum disorder, According to the CDC.

Several digital health companies are focused on creating tools to meet the needs of this community. In June, Cognoa landed a FDA De Novo for its Autism Spectrum Disorder Diagnosis Tool Canvas Dx.

Springtide, a multimodal clinic for children with developmental delays, has announced an $18.1 million round of funding. In addition, Mightier, a company that developed a biofeedback video game platform to help kids regulate their emotions, launched in 2020.